New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
08:53 EDTATRCAtriCure price target raised to $25 from $20 at Leerink
Leerink raised its price target for AtriCure shares to $25 citing the company's strong Q4 preannouncement. The firm believes the company's momentum is sustainable into 2014 and keeps an Outperform rating on the name.
News For ATRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2014
16:04 EDTATRCAtriCure completes enrollment in post approval study for Synergy Ablation system
AtriCure announced enrollment in the ABLATE Post Approval Study, or PAS, is complete. As of October 3, the ABLATE PAS enrolled 365 patients at 40 hospitals across the U.S. AtriCure expects to release preliminary data from the study in about a year, with a complete report expected to be published in three years.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use